BackRegeneron Pharmaceuticals Overview
Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals Discounted Cash Flow

DCF Analysis for REGN.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$2187.72

Current Fair Value

$2187.72
255.9% Upside

Undervalued by 255.9% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading